Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
EMA CHMP recommends Lilly’s Crohn’s therapy for EU approval
Committee for Medicinal Products for Human Use (CHMP) has recommended Eli Lilly’s Omvoh (mirikizumab) for approval in the European Union (EU) to treat adults with moderately to severely active Crohn's disease.
EMA’s CHMP committee recommends approval of Biocon Biologics’ Yesintek
EMA’s CHMP committee recommends approval of Biocon Biologics’ Yesintek: Our Bureau, Bengaluru Monday, December 16, 2024, 14:30 Hrs [IST] Biocon Biologics (BBL), a fully integr
GSK announces CHMP of the EMA recommended expanding approval of Jemperli
GSK (GSK) announced the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, has recommended expanding
GSK Jemperli Gets Positive CHMP Opinion
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More. Back To Top
Hosted on MSN
11h
CHMP Endorses Merck's Kidney Cancer Drug for Two Indications
Merck MRK announced that EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended granting conditional ...
2d
Geron announces positive CHMP opinion for Rytelo
Geron (GERN) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a ...
13h
GSK’s ViiV Healthcare says the CHMP of EMA issued positive opinion for Vocabria
GSK (GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer (PFE) and Shionogi as ...
emjreviews.com
14h
Lilly gains EU backing for drug to treat Crohn’s disease
The drug has received a nod from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).
3d
CSL Receives Positive CHMP Opinion for Garadacimab in Hereditary Angioedema (HAE)
Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today announced the European Medicines Agency's (EMA) Committee for ...
3d
Acoramidis Receives Positive CHMP Opinion for Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of acoramidis in the EU based on positive results from the ...
Medscape
4d
Self-Replicating mRNA Vaccine for COVID Prevention
Europe's
Committee
for Medicinal
Products
for Human
Use
(CHMP) recommended granting marketing authorization for two ...
Pharmabiz
21h
EMA’s human medicine committee recommends marketing approval for acoramidis for treatment of transthyretin amyloid cardiomyopathy
EMA’s human medicine committee recommends marketing approval for acoramidis for treatment of transthyretin amyloid cardiomyopathy: Berlin Monday, December 16, 2024, 13:00 Hrs [I ...
PharmaTimes
17h
CSL receives positive opinion for garadacimab in hereditary angioedema
Global biotechnology leader CSL has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for ...
Zacks.com on MSN
10h
GILD Obtains Positive CHMP Opinion for Liver Disease Drug
GILD announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (“EMA”) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback